LifeTech Scientific (SEHK:1302) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

1302 Stoklara Genel Bakış

1302 temel anali̇z
Kar Tanesi Skoru
Değerleme	0/6
Gelecekteki Büyüme	5/6
Geçmiş Performans	1/6
Finansal Sağlık	6/6
Temettüler	0/6

Ödüller

Earnings are forecast to grow 29.5% per year

Risk Analizi

Large one-off items impacting financial results

Profit margins (19.4%) are lower than last year (28%)

Significant insider selling over the past 3 months

LifeTech Scientific Corporation Rakipler

AK Medical Holdings

SEHK:1789

HK$5.9b

Beijing Chunlizhengda Medical Instruments

SEHK:1858

HK$5.5b

LEPU ScienTech Medical Technology (Shanghai)

SEHK:2291

HK$5.9b

MicroPort NeuroScientific

SEHK:2172

HK$5.5b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti LifeTech Scientific
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	HK$1.80
52 Haftanın En Yüksek Seviyesi	HK$2.63
52 Haftanın En Düşük Seviyesi	HK$1.24
Beta	0.82
11 Aylık Değişim	28.57%
3 Aylık Değişim	20.81%
1 Yıllık Değişim	-23.08%
33 Yıllık Değişim	-54.77%
5 Yıllık Değişim	29.50%
Halka arzdan bu yana değişim	620.00%

Son Haberler & Güncellemeler

Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E

Jul 05

Recent updates

Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E

Jul 05

LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear

Apr 25

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Dec 25

Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

Nov 28

At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

Nov 03

Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return

Oct 14

There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital

Jul 15

Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?

Jun 30

A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)

Jun 15

Returns At LifeTech Scientific (HKG:1302) Are On The Way Up

Apr 03

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Mar 15

Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?

Jan 22

Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital

Dec 19

Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today

Dec 06

Is LifeTech Scientific (HKG:1302) A Risky Investment?

Nov 20

An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued

Oct 12

The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence

Sep 13

Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?

Aug 28

What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?

Aug 13

LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business

Jun 08

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

May 26

Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?

May 11

LifeTech Scientific (HKG:1302) Could Easily Take On More Debt

Mar 31

Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%

Feb 21

Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?

Jan 26

Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?

Nov 25

Hissedar Getirileri

	1302	HK Medical Equipment	HK Pazar
7D	20.8%	20.3%	8.7%
1Y	-23.1%	-25.2%	19.7%

Getiri vs. Endüstri: 1302 exceeded the Hong Kong Medical Equipment industry which returned -25.2% over the past year.

Getiri vs Piyasa: 1302 underperformed the Hong Kong Market which returned 19.7% over the past year.

Fiyat Oynaklığı

Is 1302's price volatile compared to industry and market?
1302 volatility
1302 Average Weekly Movement	6.4%
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	7.1%
10% most volatile stocks in HK Market	14.7%
10% least volatile stocks in HK Market	3.6%

İstikrarlı Hisse Senedi Fiyatı: 1302 hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: 1302 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1999	1,414	Yuehui Xie	www.lifetechmed.com

Bir yatırım holding şirketi olan LifeTech Scientific Corporation, dünya çapında kardiyovasküler ve periferik vasküler hastalıklar ve bozukluklar için girişimsel tıbbi cihazlar geliştirmekte, üretmekte ve ticaretini yapmaktadır. Şirket, Yapısal Kalp Hastalıkları İşi, Periferik Vasküler Hastalıklar İşi ve Kardiyak Pacing ve Elektrofizyoloji İşi segmentleri aracılığıyla faaliyet göstermektedir. Ürünleri arasında LAmbre sol atriyal apendiks kapatma sistemlerinin yanı sıra CeraFlex, Cera, HeartR ve Konar-MF VSD oklüderleri; Ankura torasik aort anevrizması ve abdominal aort anevrizması stent greft sistemleri; Futhrough endovasküler iğne sistemleri bulunmaktadır; Fustar yönlendirilebilir ve SteerEase introduser gibi iletim sistemleri; Zoetrack kılavuz teli; Aegisy vena cava filtreleri; Cera vasküler tıkaç sistemleri; AcuMark boyutlandırma balonları; HearTone implante edilebilir kardiyak pacing sistemi; ve SeQure snare sistemleri ve kalp pilleri.

LifeTech Scientific Corporation Temel Bilgiler Özeti

LifeTech Scientific'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
1302 temel i̇stati̇sti̇kler
Piyasa değeri	HK$8.06b
Kazançlar(TTM)	HK$274.62m
Gelir(TTM)	HK$1.41b

30.4x

F/K Oranı

5.9x

P/S Oranı

1302 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
1302 gelir tablosu (TTM)
Gelir	CN¥1.28b
Gelir Maliyeti	CN¥274.29m
Brüt Kâr	CN¥1.01b
Diğer Giderler	CN¥757.58m
Kazançlar	CN¥248.64m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.054
Brüt Marj	78.58%
Net Kâr Marjı	19.42%
Borç/Özkaynak Oranı	2.9%

1302 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

1302 Stoklara Genel Bakış

Ödüller

Risk Analizi

LifeTech Scientific Corporation Rakipler

SEHK:1789

HK$5.9b

SEHK:1858

HK$5.5b

SEHK:2291

HK$5.9b

SEHK:2172

HK$5.5b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: EPS: CN¥0.046 (vs CN¥0.049 in 1H 2023)

New minor risk - Profit margin trend

LifeTech Scientific Corporation to Report First Half, 2024 Results on Aug 30, 2024

Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E

LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

Recent updates

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: EPS: CN¥0.046 (vs CN¥0.049 in 1H 2023)

New minor risk - Profit margin trend

LifeTech Scientific Corporation to Report First Half, 2024 Results on Aug 30, 2024

Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E

LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear

LifeTech Scientific Corporation, Annual General Meeting, May 27, 2024

Full year 2023 earnings released: EPS: CN¥0.06 (vs CN¥0.077 in FY 2022)

LifeTech Scientific Corporation to Report Fiscal Year 2023 Results on Mar 28, 2024

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

First half 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.05 in 1H 2022)

Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA

Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

LifeTech Scientific Corporation to Report First Half, 2023 Results on Aug 30, 2023

Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?

Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed

Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

Full year 2022 earnings released: EPS: CN¥0.077 (vs CN¥0.068 in FY 2021)

Investor sentiment improved over the past week

LifeTech Scientific Corporation Announces Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed

Insufficient new directors

Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return

LifeTech Scientific Corporation Announces FDA Approval Investigator-Initiated Pre-Market Clinical Trial of Lambre Plus Laa Closure System Obtained Medical Insurance Coverage in the US

First half 2022 earnings released: EPS: CN¥0.05 (vs CN¥0.047 in 1H 2021)

LifeTech Scientific Corporation to Report Q2, 2022 Results on Aug 30, 2022

There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital

Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?

A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)

Insufficient new directors

Returns At LifeTech Scientific (HKG:1302) Are On The Way Up

Full year 2021 earnings: EPS and revenues miss analyst expectations

LifeTech Scientific Corporation, Annual General Meeting, May 27, 2022

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?

Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital

Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today

Lifetech Scientific Corporation Announces YuranosTM Abdominal Aortic Stent Graft System Obtained Registration Approval from the China NMPA

Is LifeTech Scientific (HKG:1302) A Risky Investment?

An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued

The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence

First half 2021 earnings released: EPS CN¥0.047 (vs CN¥0.023 in 1H 2020)

Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?

What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?

Investor sentiment deteriorated over the past week

LifeTech Scientific Corporation Announces Grant of Medical Device Registration Certificate in Malaysia for Its Self-Developed Ibs Angeltm Iron Bioresorbable Scaffold System

LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?

Investor sentiment improved over the past week

Non-Executive Director has left the company

Full year 2020 earnings released: EPS CN¥0.05 (vs CN¥0.031 in FY 2019)

LifeTech Scientific (HKG:1302) Could Easily Take On More Debt

Full year 2020 earnings released: EPS CN¥0.05 (vs CN¥0.031 in FY 2019)

LifeTech Scientific Corporation to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: HK$3.62

Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%